BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7949141)

  • 1. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
    Vahdat L; Maslak P; Miller WH; Eardley A; Heller G; Scheinberg DA; Warrell RP
    Blood; 1994 Dec; 84(11):3843-9. PubMed ID: 7949141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
    Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR
    Leukemia; 1994; 8 Suppl 2():S33-7. PubMed ID: 7815834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
    Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR
    Leukemia; 1994 Jun; 8(6):929-33. PubMed ID: 8207986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
    Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
    Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "retinoic acid syndrome" in acute promyelocytic leukemia.
    Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
    Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
    Mandelli F; Diverio D; Avvisati G; Luciano A; Barbui T; Bernasconi C; Broccia G; Cerri R; Falda M; Fioritoni G; Leoni F; Liso V; Petti MC; Rodeghiero F; Saglio G; Vegna ML; Visani G; Jehn U; Willemze R; Muus P; Pelicci PG; Biondi A; Lo Coco F
    Blood; 1997 Aug; 90(3):1014-21. PubMed ID: 9242531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
    Benedetti L; Levin AA; Scicchitano BM; Grignani F; Allenby G; Diverio D; Lo Coco F; Avvisati G; Ruthardt M; Adamo S; Pelicci PG; Nervi C
    Blood; 1997 Aug; 90(3):1175-85. PubMed ID: 9242550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
    Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
    Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Camacho LH; Soignet SL; Chanel S; Ho R; Heller G; Scheinberg DA; Ellison R; Warrell RP
    J Clin Oncol; 2000 Jul; 18(13):2620-5. PubMed ID: 10893295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment.
    Chou WC; Tang JL; Yao M; Liang YJ; Lee FY; Lin MT; Wang CH; Shen MC; Chen YC; Tien HF
    Leukemia; 1997 Jul; 11(7):921-8. PubMed ID: 9204969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
    Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
    Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
    Eardley AM; Heller G; Warrell RP
    Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
    Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
    Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
    Yang J; Han Z; Pei M; Xiao N
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.